Almirall and Kaken Enter into a License Agreement for the Development and Commercialization of Efinaconazole in Europe
Shots: Kaken to receive an up front in cash and is eligible to receive milestones and royalties on the sales of the product. Almirall plans to have a pre-submission meeting with regulatory authorities in next year to prepare the approval of the product in the EU Almirall get the exclusive rights for the development and […]